Business Context and Reporting Period
This Form 8-K Current Report was filed by Nephros, Inc. on June 23, 2005. The report details a corporate governance event occurring at the Company's Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a material definitive agreement regarding equity compensation.
Material Changes
The Board of Directors, upon the recommendation of the Compensation Committee, amended the Nephros, Inc. 2004 Stock Incentive Plan (the "2004 Plan"). The key change is an increase in the maximum number of shares of common stock available for issuance:
- Previous Limit: 486,237 shares
- New Limit: 800,000 shares
This amendment was contingent upon and became effective upon approval by the Company's stockholders at the Annual Meeting on June 23, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly a notification of the stock plan amendment.
Investor Verification Checklist
- Verify the total number of shares authorized under the amended 2004 Stock Incentive Plan (800,000).
- Confirm the date of stockholder approval (June 23, 2005).
- Review the terms of the 2004 Plan to understand vesting schedules and eligibility criteria for the newly available shares.
- Check subsequent filings for the actual number of shares issued under the amended plan.